ICH‑GCP & ISO 14155
21 CFR Part 11
500+ global sites
FDA/MHRA‑ready
Global Sites
Therapeutic Areas
Clinical Development
Ophthalmology, Respiratory, Neurology, Endocrinology, Oncology, Dermatology, Infectious Diseases, Pain, Rare Disease
Protocol design, site selection, project management, monitoring, data management, biostatistics, medical writing
Phase I FIH, Phase II PoC, Phase III pivotal, Phase IV observational
ICH-GCP, 21 CFR Part 11, GDPR, ISO 14155

We deliver full-service clinical trial support across Phases I-IV: feasibility & start-up, site activation, monitoring, data management, biostatistics, medical writing and regulatory submissions. Our experienced teams and global site network help sponsors accelerate development while ensuring patient safety and data integrity.
Project Management & Monitoring: riskbased oversight, KPI tracking, vendor coordination
Data Management & Biostatistics: EDC build and validation, data cleaning, statistical analysis and reporting
Regulatory Submissions
Safety & Pharmacovigilance: case processing, medical review, aggregate reports

Feasibility, start-up, monitoring and enrollment delivery.

EDC build, data management, programming and analysis outputs.

Inspection readiness, submissions and GCP quality systems.
Our mission is to advance healthcare by delivering high-quality, efficient clinical trials that bring safe and effective therapies to patients faster. We combine scientific rigor, operational excellence, and patient-centered design to exceed sponsor and regulatory expectations.
Clinical operations, safety, biometrics, medical writing, and regulatory strategy to support your program end‑to‑end.
Solid tumors, hematology, immuno-oncology, biomarker-driven designs
Epilepsy, movement disorders, neurodegeneration, rare CNS disorders
Asthma, COPD, interstitial lung disease, pulmonary infections
Retina, glaucoma, anterior segment, inflammatory eye disease
Diabetes, obesity, thyroid and metabolic disorders
Psoriasis, atopic dermatitis, acne, autoimmune skin disease
Antivirals, antibacterials, vaccines, emerging pathogens
Acute and chronic pain, neuropathic and musculoskeletal conditions
Genetic and orphan indications, natural history and interventional trials